Point72 Asset Management
TWST icon

Point72 Asset Management’s Twist Bioscience TWST Stock Holding History

Point72 Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,000
Closed -$2.06M – 2461
2024
Q1 		$2.06M Sell
60,000
-50,000
-45% -$1.8M 0.01% 1258
2023
Q4 		$4.05M Buy
+110,000
New +$2.54M 0.01% 1001

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's TWST Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Twist Bioscience (TWST) in Q1 2026: 669,732 shares worth $31.8M. The stake represents 0.04% of the portfolio and ranks #580 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in TWST as recently as Q3 2025.

Point72 Asset Management first reported a position in TWST in Q1 2022 and has held it in 9 quarters since. The position peaked at $79.4M in Q2 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Point72 Asset Management held 669,732 shares of Twist Bioscience worth $31.8M as of Q1 2026.
  • Twist Bioscience was a new Point72 Asset Management position in Q1 2026.
  • Twist Bioscience made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #580 holding.
  • Point72 Asset Management first reported a position in Twist Bioscience in Q1 2022 and has held it in 9 quarters since.
  • Point72 Asset Management's Twist Bioscience position peaked at $79.4M in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.